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enzymes must be active in the circulation for each milligram of OPs to be neutralized. Instead of simply acting as scavengers, OP hydrolases can actively hydrolyze OPs. This reThe acute toxicity of organophosphorus (OP) compounds duces the amount of OP in the body and prevents the inhibiin mammals is due to their irreversible inhibition of acetyl-tion of body esterases. Carbamates are also used in OP thercholinesterase (AChE, EC 3.1.1.7) in the nervous system, apy. The centrally active carbamate, physostigmine, and the which leads to increased synaptic acetylcholine levels. The peripherally active pyridostigmine have been demonstrated inhibition of AChE causes a cholinergic crisis producing to protect against the fatal effects of nerve agents such as several symptoms of poisoning, e.g., salivation, miosis, diar-soman (Leadbeater et al., 1985) . rhea, CNS depression, tremors, and respiratory failure,
In our previous studies, we have examined the ability of which may be lethal (Ecobichon, 1991 olive oil). Phosphotriesterase (66 mmol/min 1 ml/g body wt and 6 mg/g man, and tabun. Our findings have shown that the phosphobody wt in volume of approximately 0.15 ml) or 2-PAM (30 mg/kg body triesterase-treated mice tolerated 33-to 50-fold higher parawt in a volume of approximately 0.15 ml) was injected i.v. 30 min after oxon doses than controls (Tuovinen et al., 1994) . The i.v. DFP. The control animals received i.v. saline and/or i.p. olive oil. To avoid injected phosphotriesterase protected the serum and brain possible toxic symptoms, the mice received sc atropine sulfate (37.5 mg/ kg in a volume of approximately 0.15 ml saline) immediately after the OP ChE activities in mice, when it was administered before injection. At 1, 3, 6, and 24 hr after the DFP exposure, the mice were or after paraoxon (diethyl-p-nitrophenylphosphate) (Kalistesacrificed by carbon dioxide, and blood samples (approx. 1.0 ml) were Korhonen et al., 1993; Tuovinen et al., 1994 Tuovinen et al., , 1996a . It also drawn by cardiac puncture into heparinized tubes. The 25 ml of heparinized prevented ChEs inhibition following DFP, sarin, or soman blood was diluted with 20 vol of 0.1% Triton in 50 mM sodium phosphate intoxications (Tuovinen et al., 1994 (Tuovinen et al., , 1996a . Moreover, we buffer. After that brain and lungs were quickly dissected and immediately frozen on dry ice. Plasma was separated with a hematocrit centrifuge at found that recovery of nonaged paraoxon inhibited ChEs was 1000g for 10 min at 4ЊC. The samples were stored at 075ЊC until measured. more rapid in phosphotriesterase-treated mice (Tuovinen et Enzyme assays. ChE activities were measured spectrophotometrically al., 1994).
at 410 nm at 37ЊC with the method of Ellman et al. (1961) using acetylthio-
The aims of the present study were to investigate whether choline iodide as the substrate for brain and lung and butyrylthiocholine a combination of eptastigmine and phosphotriesterase or 2-iodide for plasma. AChE activity in the blood was measured using propio-PAM therapy could improve the ChE activities after DFP nylthiocholine iodide as the substrate according to the method of Augustinexposure. Theoretically, carbamate should increase the sson et al. (1978) . AChE activity was measured after the inhibition of BChE with a specific inhibitor, Astra 1397-HCl. The blood samples were amount of OP in a free form, and phosphotriesterase should preincubated with the Astra-compound for 2 min before addition of the improve the possibility that the OP molecules become hysubstrate. Paraoxon hydrolyzing activity was measured from plasma samdrolyzed before they inhibit the esterases. Moreover, we ples using paraoxon as the substrate. The assay method differed from the wanted to test the efficacy of eptastigmine-oxime combina-previous method (Tuovinen et al., 1994) . In this assay, the enzyme activity tion and compare it to treatment with phosphotriesterase.
was measured in 0.0125 M borate buffer (pH 7.5) containing 50 mM cobalt in place of 300 mM calcium. The activity was spectrophotometrically monitored at 405 nm at 37ЊC.
MATERIALS AND METHODS

Protein. Protein content of the tissue homogenates was measured by the dye-binding method of Bradford (1976).
Chemicals and materials. The derivative of physostigmine, heptylphy-
Statistical analysis. The enzymatic data are presented as means { SD. sostigmine (eptastigmine; MF-201 tartrate; molecular weight 359), was
Comparison of enzyme activities between groups were calculated using kindly supplied by Mediolanum (Milano, Italy). The compound was disone-way analysis of Kruskal Wallis and followed by Mann-Whitney U solved in 0.9% NaCl (saline) solution. The phosphotriesterase enzyme is test. The p-value 0.05 or less was used as the level of statistical significance. present in the soil bacteria, Pseudomonas diminuta and Flavobacterium sp. The phosphotriesterase coding gene from P. diminuta was expressed in Escherichia coli and a protein preparation was purified according to the et al. (1992) at Texas A&M University. Phosphotriesterase was dissolved in 50 mM Hepes buffer, pH 8.5, 1.0 mg/ml with 12,000 mmol/min 1 ml (12,000 mmol/min 1 mg prot.) of paraoxon hydrolyzing Phosphotriesterase (approx. 1800 mmol/min 1 ml/mouse) activity. In the purification system the naturally occurring Zn 2/ was replaced increased paraoxon hydrolyzing activity (POase) in mouse with Co 2/ (Omburo et al., 1992) . Pralidoxime-2-chloride (2-PAM) was plasma by up to 10,000-fold compared to control level, meapurchased from the Aldrich-Chemical Co. (Steinheim, Germany) and dissured half an hour after the administration of the enzyme. solved in saline. DFP was purchased from Fluka AG (Buchs, Switzerland) and dissolved in olive oil. Acetylthiocholine, butyrylthiocholine, and propi-The activity rapidly decreased during the first 3 hr, and it onylthiocholine iodide, the substrates for ChEs, and other reagents such as was near to the control level at 24 hr ( Fig. 1) . Eptastigmine bovine albumin, atropine sulfate, 5,5-dithio-bis(2-nitrobenzoic acid) or 2-PAM had no effect on plasma POase activities (data (DTNB), 4,4-dithiopyridine (PDS), and Triton X-100 were purchased from not shown).
RESULTS
method of Omburo
Sigma Chemical Co. (St. Louis, MO). Paraoxon, the substrate for paraoxIn brain, DFP inhibited AChE activity by 65% within the onase and phosphotriesterase, was purchased from Ehrenstorfer (Augsburg, Germany). Astra 1397-HCl (10-diethylaminopropionyl phenothiazine-HCl), first hour, and the activity did not recover during the followthe specific inhibitor for BChE, was purchased from Astra (Södertälje, up period ( Fig. 2A) . Eptastigmine (0.9 mg/kg) reduced brain Sweden).
AChE activity by 30% and the activity had recovered to Animals. The animals used were 11-to 13-week-old CD 2 F 1 male mice 90% of control in 24 hr. Phosphotriesterase treatment in-(25-29 g) (National Laboratory Animal Center, Kuopio, Finland). They creased the level of active AChE in brain by 20 to 40%.
were housed in groups of six animals in stainless-steel cages with aspen
The activity had still not significantly recovered after 24 hr.
bedding (Tapvei Co., Kaavi, Finland). The mice were housed in a controlled environment: temperature 22 { 1ЊC, relative humidity 50 { 10%, and light The 2-PAM treatment did not offer any protection against period of 12 hr (07.00-19.00). Pellets of mouse diet (R36, Lactamin AB, DFP or reactivate brain AChE. Eptastigmine, even though Södertälje, Sweden) and water were freely available. This study was ap-it had an inhibitory effect on AChE, did not increase the proved by the Ethical Committee for Animal Experiments of the University inhibition of activity in DFP administered animals. After 24 of Kuopio.
hr, when the effect of eptastigmine had disappeared, the Experiments. Eptastigmine (0.9 mg/kg body wt in volume of approxienzyme activity was increased from 45 to 75% in DFP intoxmately 0.2 ml saline) was injected into the tail vein 10 min prior to the i.p. injection of DFP (1.8 mg/kg body wt in volume of approximately 0.5 ml icated mice. The combination of eptastigmine-phospho-the first hour, and the activity recovered spontaneously to 35% of the control between 6 and 24 hr (Fig. 2D) . Eptastigmine inhibited plasma BChE activity by 60% during the first 80 min. However, by 6 hr the activity had recovered almost to normal. Phosphotriesterase protected the enzyme activities for the entire 24 hr. But this was not the case with 2-PAM. The eptastigmine treatment alone did not protect plasma ChE activities. It did, however, improve the protection efficacy of phosphotriesterase.
DISCUSSION
At the time point of 1 hr, the measured paraoxon hydrolyz -FIG. 1 . The effect of phosphotriesterase (PTE; 66 mmol/min 1 ml/g body wt) administration on plasma paraoxon hydrolyzing activity (POase) ing capacity of phosphotriesterase was greater than in our in mice, when the relative activity in untreated mice was 1.0. PTE or saline previous study (Tuovinen et al., 1996a) . This is due to the were given i.v. 30 min after DFP or olive oil. Atropine sulfate (appr. 37.5 fact that CoCl 2 was substituted for CaCl 2 as cofactor in the mg/kg) was injected sc immediately after DFP. POase activity in mice that assay method of POase. On the other hand, the control had not received PTE was 165 { 40 nmol/min 1 ml. Means { SD are plasma POase activities were threefold greater in our previgiven, n Å 5 or 6. ous study (496 vs. 165 nmol/min 1 ml). Presumably, Ca 2/ is a better cofactor than Co 2/ for the native POase (Gan et al., 1990; Dave et al., 1993) . However, the difference in triesterase protected the enzyme activities in brain better than eptastigmine-2-PAM, but phosphotriesterase combined plasma POase activity after phosphotriesterase treatment may also be due to the differences in time schedules used. with eptastigmine did not, however, provide any additional protection when compared with phosphotriesterase-or eptas-In the previous study, the plasma POase activities were measured 80 min after the phosphotriesterase administration, tigmine-treatments on their own.
In lung, the ChE activity was maximally inhibited by DFP whereas now the activity was assayed 30 min after the phosphotriesterase treatment. The degradation of phosphotriesterat the time point of 3 hr, and it showed virtually no sign of recovery (Fig. 2B) . Eptastigmine reduced lung ChE activity ase in plasma is known to take place very rapidly. According to Ashani et al. (1991b) the enzyme activity in plasma of by 50% during the first 80 min, and the activity recovered to the normal level within 24 hr. The antidotes and their mice which had received a phosphotriesterase-like enzyme stayed at a constant level only during the first 10-15 min different combinations did not significantly protect the ChE activity against DFP. At 24 hr after treatment, 2-PAM even after i.v. injection. The activity was cleared from the circulation within 150 min. increased the degree of inhibition. Phosphotriesterase, as well as eptastigmine, seemed, however, to have a slight proThis study showed that phosphotriesterase alone decreased the acute toxicity of DFP better than 2-PAM. An tective effect on the activity, at the time point of 24 hr.
In erythrocytes, the maximum ChE inhibition after DFP i.v. injection of phosphotriesterase (both alone and in combination with eptastigmine) as late as 30 min after DFP expoinjection occurred within 3 hr, after which the activity spontaneously recovered to the normal level during the next 3 sure was able to protect brain ChE activity better than 2-PAM. Moreover, eptastigmine alone increased brain ChE hr (Fig. 2C) . The inhibitory effect of eptastigmine was greater than that of DFP, and it also lasted for a longer activities which had been inhibited by DFP exposure. Harris et al. (1991) have reported that physostigmine can protect time. Phosphotriesterase could not prevent the inhibition of enzyme caused by DFP exposure. 2-PAM-DFP-treated ani-ChEs against tabun and sarin toxicity. Physostigmine has also been reported to decrease ChE inhibition in brain and mals had generally the same activity levels as those treated with DFP alone. Surprisingly, however, 2-PAM seemed to serum in soman intoxication (Miller et al., 1993) . In our previous study (Tuovinen et al., 1996b) , eptastigmine-phosslow down the recovery of enzyme activity. Eptastigmine-DFP treatment increased the inhibition of ChEs compared photriesterase combination protected the ChE activities in plasma and lung, but not in brain, when phosphotriesterase to mice receiving only DFP. The combination of eptastigmine with either phosphotriesterase or 2-PAM treatments was administered 10 min after DFP exposure. In the present study, phosphotriesterase was administered 30 min after DFP did not significantly supplement the protective effects of the antidotes. For the first 6 hr the eptastigmine-2-PAM so that the enzyme activities would differ more from control level in phosphotriesterase-treated mice. When phosphocombination provided better protection of the enzyme activities than eptastigmine-phosphotriesterase.
triesterase was now administered 20 min later, the ChEs were inhibited by 30% more in the DFP-phosphotriesterase In plasma, DFP inhibited BChE activity by 90% within FIG. 2 . The protective effect of heptylphysostigmine tartrate (EPTA; 0.9 mg/kg), PTE (66 mmol/min 1 ml/g body wt) and/or pralidoxime (2-PAM; 30 mg/kg) on brain AChE (A), lung AChE (B), erythrocyte AChE (C), and plasma BChE (D) activities after DFP (1.8 mg/kg) exposure in mice. EPTA was given i.v. 10 min prior to the ip injection of DFP. Thirty minutes later mice received PTE or 2-PAM. In addition, atropine sulfate (approx. 37.5 mg/kg) was injected sc immediately after DFP. Control activities were brain AChE 223 { 11 nmol/min 1 mg protein, lung AChE 27 { 4 nmol/min 1 mg protein, erythrocyte AChE 1 711 { 268 nmol/min 1 ml, and plasma BChE 4 326 { 318 nmol/min 1 ml. Means { SD are given, n Å 5 or 6. *p õ 0.05 compared to the control; 1 p õ 0.05 compared to the DFP-treated mice; 2 p õ 0.05 compared to the DFP-2-PAM-treated mice; 3 p õ 0.05 compared to the DFP-PTE-treated mice; 4 p õ 0.05 compared to the EPTA-DFP-treated mice; 5 p õ 0.05 compared to the EPTA-DFP-2-PAM-treated mice; 6 p õ 0.05 compared to the EPTA-DFP-PTE-treated mice. EPTA-treated mice were compared only with the control mice.
group. Nonetheless, phosphotriesterase protected the enzyme terase was given 30 min after DFP. This provides further evidence that it is the first minutes after exposure which activities. Eptastigmine combined with phosphotriesterase, however, prevented this additional enzyme inhibition in are critical for the effectiveness of phosphotriesterase in OP poisonings. brain. Eptastigmine pretreatment would seem to provide more protection for ChE during the first critical minutes after
In erythrocytes, phosphotriesterase given alone showed the best antidotal effect against DFP. DFP exposure.
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